0 CHECKOUT
Global Array Instruments Market 2015-2019 - Product Image

Global Array Instruments Market 2015-2019

  • ID: 3280763
  • June 2015
  • Region: Global
  • 71 pages
  • TechNavio
1 of 5

FEATURED COMPANIES

  • Affymetrix
  • BioChain Institute
  • CombiMatrix
  • Great Basin
  • OriGene Technologies
  • Qiagen
  • MORE

About array instruments

An array is the technology used in laboratories that quantitatively and simultaneously monitors the expression of thousand genes. The high-throughput approach of microarrays help locate mutations in genotype, measure and detect gene expressions at the mRNA or at the protein level, and locate chromosomal expressions. They work on basic aspects such as hybridization, coupling biomolecules to a platform, sample preparation for detection, data analysis, and scanning. Over the years, array instruments have helped in refining molecular biology, cell biology, genetics, and molecular pathology; synthesizing or sequencing nucleic acids; and accelerating drug discovery processes.

The analysts forecast the global array instruments market to grow at a CAGR of 12.48 % over the period 2014-2019.

Covered in this report
The global array instruments market can be divided into three segments: DNA microarrays, protein microarrays, and others including tissue microarrays and cell microarrays. This report covers the present scenario and the growth prospects of the global array instruments market for the period 2015–2019. To calculate the market size, READ MORE >

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Affymetrix
  • BioChain Institute
  • CombiMatrix
  • Great Basin
  • OriGene Technologies
  • Qiagen
  • MORE

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market overview
03.2 Product offerings
04. Market Research Methodology
04.1 Market research process
04.2 Research methodology
05. Introduction
06. Market Landscape
06.1 Market overview
06.2 Market size and forecast
06.3 Five forces analysis
07. Reimbursement and Coverage
08. Market Segmentation by Application
08.1 DNA microarray
08.1.1 Market size and forecast
08.2 Protein microarray
08.2.1 Market size and forecast
08.3 Others
08.3.1 Market size and forecast
09. Geographical Segmentation
09.1 Array instruments market in Americas
09.1.1 Market size and forecast
09.2 Array instruments market in EMEA
09.2.1 Market size and forecast
09.3 Array instruments market in APAC
09.3.1 Market size and forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and Their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and Their Impact
17. Vendor Landscape
17.1 Competitive scenario
17.1.1 Key news
17.1.2 Mergers and acquisitions
17.2 Market share analysis 2014
17.2.1 Affymetrix
17.3 Other prominent vendors
18. Key Vendor Analysis
18.1 Affymetrix
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue 2014
18.1.4 Business Segmentation by Revenue 2013 and 2014
18.1.5 Geographical Segmentation by Revenue 2014
18.1.6 Business Strategy
18.1.7 Recent Developments
18.1.8 SWOT Analysis
18.2 Agilent Technologies
18.2.1 Key facts
18.2.2 Business overview
18.2.3 Business segmentation by revenue 2013
18.2.4 Business segmentation by revenue 2012 and 2013
18.2.5 Geographical segmentation by revenue 2013
18.2.6 Business strategy
18.2.7 Recent developments
18.2.8 SWOT analysis
18.3 Illumina
18.3.1 Key facts
18.3.2 Business overview
18.3.3 Business segmentation
18.3.4 Geographical segmentation by revenue 2013
18.3.5 Business strategy
18.3.6 Key information
18.3.7 SWOT analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market research methodology
Exhibit 2: Global array instruments market 2014-2019 ($ millions)
Exhibit 3: Segmentation of global array instruments market by application
Exhibit 4: Segmentation of global array instruments market by application 2014
Exhibit 5: Segmentation of global array instruments market by application 2019
Exhibit 6: Global DNA microarray market 2014-2019 ($ millions)
Exhibit 7: Global protein microarrays market 2014-2019 ($ millions)
Exhibit 8: Global other microarrays market 2014-2019 ($ millions)
Exhibit 9: Global array instruments market by application 2014-2019
Exhibit 10: Segmentation of global array instruments market by geography 2014
Exhibit 11: Segmentation of global array instruments market by geography 2014-2019
Exhibit 12: Array instruments market in Americas 2014-2019 ($ millions)
Exhibit 13: Array instruments market in EMEA 2014-2019 ($ millions)
Exhibit 14: Array instruments market in APAC 2014-2019 ($ millions)
Exhibit 15: Key takeaways: Affymetrix
Exhibit 16: Key takeaways: Agilent Technologies
Exhibit 17: Key takeaways: Illumina
Exhibit 18: Affymetrix: Business Segmentation by Revenue 2013
Exhibit 19: Affymetrix: Business Segmentation by Revenue 2013 and 2014
Exhibit 20: Affymetrix: Geographical Segmentation by Revenue 2014
Exhibit 21: Agilent Technologies: Business segmentation by revenue 2013
Exhibit 22: Agilent Technologies: Business segmentation by revenue 2012 and 2013 ($ billions)
Exhibit 23: Agilent Technologies: Geographical segmentation by revenue 2013
Exhibit 24: Illumina: Business segmentation
Exhibit 25: Illumina: Geographical segmentation by revenue 2013

Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Affymetrix
  • BioChain Institute
  • CombiMatrix
  • Great Basin
  • OriGene Technologies
  • Qiagen
  • MORE

The author Announces the Publication of its Research Report – Global Array Instruments Market 2015-2019

The author recognizes the following companies as the key players in the global array instruments market: Affymetrix, Agilent Technologies and Illumina

Other Prominent Vendors in the market are: Applied Microarrays, Arrayit, Asterand, AutoGenomics, AyoxxA, Bayer Technology Services, BioCat, BioChain Institute, BioGenex Laboratories, Biolog, BioMérieux, Biometrix Technology, Bio-Rad Laboratories, Cancer Genetics, Cepheid, CombiMatrix, EMD Millipore, Exiqon, Fluidigm, Gamida for Life Group, GE Healthcare, Genentech, Grace Bio-Labs, Great Basin, GVS, InDevR, ISU ABXIS, Laboratory Corporation of America Holdings, LC Sciences, Luminex, Meso Scale Diagnostics, Mingyuan Medicare Development Company, Novus Biologicals (a Bio-Techne company), OncoCyte, OriGene Technologies, Orla Protein Technologies, Oxford Gene Technology, Partek, Pepscan, Perkin Elmer, Phalanx Biotech Group, ProteoGenix, Qiagen, RayBiotech, Retrogenix, Takara Bio, Tecan, Theranostic Health, Thermo Fisher Scientific, US Biomax, Veredus Laboratories and Zyagen

Commenting on the report, an analyst from the team said: “Sophisticated technologies and tools such as NGS and microarray platforms enable rapid, large-scale, quantitative assessments of molecular and cellular biology procedures. Important discoveries in the biomedical field through the use of DNA and protein microarrays have already been implemented in clinical diagnostics, especially in oncology where they have had a broader impact. Genomic testing technologies to identify oncogenic variants and their response to specific drugs are widely used to develop personalized medicines. These advances enable both the generation and analysis of big data in applied life sciences research and basic information transfer during drug development.”

According to the report, advances in the technology and sophistication of instruments used in healthcare have increased the demand for array instruments. Novel microarrays have been developed that can advance the fields of cell biology, genetics, and molecular biology and accelerate drug discovery processes. The design of fiber-optic microarrays and the merging of microarrays with microfluidics for bioassays are some new developments in the market. For instance, BioArray Solutions, Illumina, and Tm Bioscience are developing different types of array, such as bead-based arrays, to perform tests and make diagnoses.

Further, the report states that lack of skilled technicians and inadequate data management is hindering the market growth.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Note: Product cover images may vary from those shown
4 of 5

- Affymetrix
- Agilent TechnologiesIllumina
- Applied Microarrays
- Arrayit
- Asterand
- AutoGenomics
- AyoxxA
- Bayer Technology Services
- BioCat
- BioChain Institute
- BioGenex Laboratories
- Biolog
- BioMérieux
- Biometrix Technology
- Bio-Rad Laboratories
- Cancer Genetics
- Cepheid
- CombiMatrix
- EMD Millipore
- Exiqon
- Fluidigm
- Gamida for Life Group
- GE Healthcare
- Genentech
- Grace Bio-Labs
- Great Basin
- GVS
- InDevR
- ISU ABXIS
- Laboratory Corporation of America Holdings
- LC Sciences
- Luminex
- Meso Scale Diagnostics
- Mingyuan Medicare Development Company
- Novus Biologicals (a Bio-Techne company)
- OncoCyte
- OriGene Technologies
- Orla Protein Technologies
- Oxford Gene Technology
- Partek
- Pepscan
- Perkin Elmer
- Phalanx Biotech Group
- ProteoGenix
- Qiagen
- RayBiotech
- Retrogenix
- Takara Bio
- Tecan
- Theranostic Health
- Thermo Fisher Scientific
- US Biomax
- Veredus Laboratories
- Zyagen

Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • STILLE Surgical Instruments
  • Alcon Incorporated
  • Hoya Surgical Optics, Inc.
  • Hollister Inc.
  • PerkinElmer, Inc.
  • Cyberonics, Inc.